Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Meta Platforms (Facebook)
META
|
+$742M |
| 3 |
Wells Fargo
WFC
|
+$363M |
| 4 |
Salesforce
CRM
|
+$310M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$869M |
| 2 |
Apple
AAPL
|
+$693M |
| 3 |
PPLI
People Inc
PPLI
|
+$488M |
| 4 |
Expedia Group
EXPE
|
+$409M |
| 5 |
Charter Communications
CHTR
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.04% |
| 2 | Healthcare | 2.79% |
| 3 | Financials | 2.32% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5801
SoundThinking
SSTI
$81.6M
| $1.05M | ﹤0.01% |
33,801
+15,796
| +88% | +$434K |
|
5802
Akebia Therapeutics
AKBA
$242M
| $1.05M | ﹤0.01% |
417,129
+368,387
| +756% | +$3.23M |
|
|
HONE
5803
DELISTED
HarborOne Bancorp
HONE
| $1.05M | ﹤0.01% |
129,647
+72,914
| +129% | +$623K |
|
5804
CALL
iPath Series B S&P 500 VIX Mid-Term Futures ETN
VXZ
$30.5M
| $1.05M | ﹤0.01% |
7,700
+250
| +3% | +$33.3K |
|
5805
Abeona Therapeutics
ABEO
$342M
| $1.04M | ﹤0.01% |
40,994
-17,466
| -30% | -$1.1M |
|
5806
LeMaitre Vascular
LMAT
$1.88B
| $1.04M | ﹤0.01% |
32,117
+10,984
| +52% | +$330K |
|
5807
Resources Connection
RGP
$146M
| $1.04M | ﹤0.01% |
90,476
-18,520
| -17% | -$220K |
|
5808
PUT
Worthington Enterprises
WOR
$2.87B
| $1.04M | ﹤0.01% |
41,523
+6,650
| +19% | +$162K |
|
5809
PUT
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$167M
| $1.04M | ﹤0.01% |
18,100
-24,500
| -58% | -$1.42M |
|
5810
Krystal Biotech
KRYS
$9.83B
| $1.04M | ﹤0.01% |
24,224
+2,595
| +12% | +$113K |
|
5811
Fidelity International High Dividend ETF
FIDI
$365M
| $1.04M | ﹤0.01% |
65,814
+19,020
| +41% | +$313K |
|
5812
Cambria Global Value ETF
GVAL
$602M
| $1.04M | ﹤0.01% |
+60,420
| New | +$1.09M |
|
|
SVM
5813
Silvercorp Metals
SVM
$2.66B
| $1.04M | ﹤0.01% |
144,123
+89,303
| +163% | +$659K |
|
5814
iShares Core Dividend ETF
DIVB
$1.8B
| $1.04M | ﹤0.01% |
36,262
+26,967
| +290% | +$773K |
|
5815
CALL
Royalty Pharma
RPRX
$26.1B
| $1.04M | ﹤0.01% |
24,700
+6,400
| +35% | +$275K |
|
|
MDLA
5816
PUT
DELISTED
Medallia, Inc.
MDLA
| $1.04M | ﹤0.01% |
37,900
-37,800
| -50% | -$1.15M |
|
5817
BancFirst
BANF
$3.89B
| $1.04M | ﹤0.01% |
25,409
-33,676
| -57% | -$1.42M |
|
5818
CALL
PTC Therapeutics
PTCT
$5.98B
| $1.04M | ﹤0.01% |
22,200
-10,200
| -31% | -$502K |
|
|
ALTR
5819
DELISTED
Altair Engineering Inc
ALTR
| $1.04M | ﹤0.01% |
24,699
-11,766
| -32% | -$473K |
|
|
WPS
5820
DELISTED
iShares International Developed Property ETF
WPS
| $1.04M | ﹤0.01% |
32,961
-20,072
| -38% | -$631K |
|
5821
Cytosorbents Corp
CTSO
$25.1M
| $1.03M | ﹤0.01% |
129,803
+34,164
| +36% | +$308K |
|
5822
PUT
LPL Financial
LPLA
$29.2B
| $1.03M | ﹤0.01% |
13,500
-36,700
| -73% | -$2.91M |
|
5823
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.14B
| $1.03M | ﹤0.01% |
13,610
-15,470
| -53% | -$1.19M |
|
|
PAND
5824
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| $1.03M | ﹤0.01% |
+90,316
| New | +$1.54M |
|
|
PARAA
5825
DELISTED
Paramount Global Class A
PARAA
| $1.03M | ﹤0.01% |
34,140
+4,883
| +17% | +$143K |
|
Similar funds
Ken Griffin's Q3 2020 Portfolio in Review
As of Q3 2020, Ken Griffin held 11,253 positions worth $353B, up 26% from $280B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin deployed $24.6B of net new capital in Q3 2020, opening 1,597 new positions and adding to 4,071 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 4,016,602 shares worth $256M.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Amazon, an estimated $869M trimmed.
- Ken Griffin's largest Q3 2020 buy was iShares MSCI EAFE ETF: 4,016,602 shares worth $256M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $1.04B increase.
- Ken Griffin's biggest Q3 2020 reduction was Amazon, cutting an estimated $869M.
- Ken Griffin fully exited Intel in Q3 2020, selling an estimated $249M.
- Ken Griffin's ten largest holdings make up 36% of its $353B portfolio in Q3 2020.
- Ken Griffin opened 1,597 new positions and closed 1,263 in Q3 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $353B.
Based on Citadel Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.